Brief: RLS Global Continues To Develop Its Wound Care Business Area

RLS Global AB

24/02/2020 07:35

Feb 24 (Reuters) - RLS Global AB  RLSC.ST :
    * RLS GLOBAL CONTINUES TO DEVELOP ITS WOUND CARE BUSINESS
AREA AND
SELLS OFF THE DENTAL CARE PORTFOLIO
    * RLS GLOBAL'S STRATEGY IS TO ENSURE A STRONG MARKET
PENETRATION
FOR CHLORASOLV TOGETHER WITH REGIONAL/GLOBAL PARTNERSHIPS
    * DURING 2020, RLS WILL INITIATE PRE-CLINICAL ACTIVITIES
WITH AIM
OF BROADENING PRODUCT PORTFOLIO WITHIN NEW CLINICAL AREAS. NEW
CLINICAL INDICATIONS THAT RLS WILL EVALUATE ARE BURNS AND OTHER
CLINICAL INDICATIONS OUTSIDE WOUND CARE.
    * TRANSACTION CONSISTS OF A CASH PAYMENT OF 4 MSEK AND AN
ADDITIONAL CONSIDERATION UNTIL 2032 BASED ON A PERCENTAGE OF
PRODUCTS SOLD.
    * WITH GIVEN BACKGROUND, RLS GLOBAL WILL SELL OFF ITS DENTAL
CARE
PORTFOLIO IN ORDER TO OPTIMIZE COMPANY'S RESOURCES
    * RLS WILL SELL PERISOLV TO REGEDENT AG

Source text for Eikon:  ID:nWkr6tkTRm 
Further company coverage:  RLSC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))